Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
CytoDyn Inc CYDY
(Total Views: 503)
Posted On: 06/17/2021 9:02:17 AM
Post# of 154286
Posted By: CTMedic
Re: Shopcop7 #93928
Weekly doses of Leronlimab in LH trial rather than 2 doses in CD12 with evaluation three weeks after last dose.

Drugs work when administered.

I believe Leronlimab works.

I’m not at Ohm’s level, but have read more on the immune system and CCR5 blockade/CCL3/4/5 attenuation that I could have imagined.

FWIW, Patterson et al using maraviroc in their clinic as they believe in the value of CCR5 attenuation in LH, but are unable to use Leronlimab.

Bubbly back on ice for Monday.














(9)
(0)









  • New Post - Investors HangoutNew Post

  • Public Reply - Investors HangoutPublic Reply

  • Private Reply - Investors HangoutPrivate Reply

  • Board - Investors HangoutBoard

  • More - Investors HangoutMore

  • Keep Post - Investors HangoutKeep Post
  • Report Post - Investors HangoutReport Post
  • Home - Investors HangoutHome
  • Mailbox - Investors HangoutMailbox
  • Boards - Investors HangoutBoards
  • Favorites - Investors HangoutFavorites
  • Whats Hot! - Investors HangoutWhats Hot!
  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site